Target intelligence / Profile preview

DNA annealing helicase and endonuclease ZRANB3 (ZRANB3)

Target
ZRANB3
Molecular classification
Enzyme, Endonuclease, Helicase, SNF2-family ATPase, Zinc finger protein
01

Overview

DNA annealing helicase and endonuclease ZRANB3 is a structure-specific, ATP-dependent enzyme belonging to the SNF2-family of ATPases, with both helicase and HNH endonuclease activities[1][2][3][4]. ZRANB3 is crucial for resolving replication stress by processing branched DNA structures and stalled replication forks, being recruited to these sites via interactions with polyubiquitinated PCNA and branched DNA. It aids DNA repair and genome stability by cleaving replication fork intermediates and catalyzing fork regression, thus preventing fork collapse and limiting inappropriate recombination[1][2][3][4]. ZRANB3 contains an N-terminal helicase domain, a PIP box and APIM motif (for PCNA binding), an Npl4-type zinc finger, and a C-terminal HNH endonuclease domain[3]. Mutational disruption may predispose to cancer and other diseases associated with genome instability, but direct therapeutic targeting is not yet established.

Other names
Annealing helicase 2AH2Zinc finger Ran-binding domain-containing protein 3ZRAB3DKFZP434B17274933425L19Rik
02

Biological functions

DNA repairDNA replicationReplication fork processingResponse to replication stressFork regression via annealing helicase activityRegulation of genome stability
03

Disease associations

Cancer (mutation or malfunction may be implicated in genome instability, a cancer hallmark)[3]Schimke immunoosseous dysplasia (rare disease association)[4]Chlorhexidine allergy (rare disease association)[4]Other (broad relevance in diseases with replication stress/genomic instability)

Beyond the preview

Go deeper on DNA annealing helicase and endonuclease ZRANB3 (ZRANB3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA annealing helicase and endonuclease ZRANB3 (ZRANB3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call